Administration of Vaccines and Parenteral Medications in Home Care Settings: Safety and Guidelines (Last Updated: Mar 2, 2020)
Project Line:
Reference List
Current Filters
IVIG Evidence Bundle Remove
Off-Label Use of Intravenous Immunoglobulin: A Review of Clinical Effectiveness (Last Updated: Nov 1, 2017)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Recurrent Spontaneous Abortion: A Review of Clinical Effectiveness (Last Updated: May 11, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Non-Neurological Paraneoplastic Disorders: A Review of Clinical Effectiveness (Last Updated: Apr 30, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: A Review of Clinical Effectiveness (Last Updated: Apr 20, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Autoimmune or Inflammatory Conditions: A Review of Clinical Effectiveness (Last Updated: Apr 6, 2018)
Project Line:
Health Technology Review
Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: Clinical Effectiveness (Last Updated: Nov 3, 2017)
Project Line:
Reference List
Off-Label Use of Intravenous Immunoglobulin for Autoimmune or Inflammatory Conditions: Clinical Effectiveness (Last Updated: Oct 30, 2017)
Project Line:
Reference List
Off-Label Use of Intravenous Immunoglobulin for Solid Organ Transplant Rejection, Paraneoplastic Disorders, or Recurrent Miscarriage: Clinical Effectiveness (Last Updated: Nov 7, 2017)
Project Line:
Reference List
Off-Label Use of Intravenous Immunoglobulin for Solid Organ Transplant Rejection: A Review of Clinical Effectiveness (Last Updated: Apr 30, 2018)
Project Line:
Health Technology Review